Characterization_of_childhood_acute_leukemia_with_multiple_myeloid_and_lymphoid_markers_at_diagnosis_and_at_relapse._To_define_the_clinical_and_biologic_significance_of_childhood_acute_mixed-lineage_leukemia_diagnosed_by_stringent_criteria,_we_studied_25_cases_of_acute_lymphoblastic_leukemia_expressing_greater_than_or_equal_to_2_myeloid-associated_antigens_(My+_ALL),_and_16_cases_of_acute_myeloid_leukemia_expressing_greater_than_or_equal_to_2_lymphoid_associated_antigens_(Ly+_AML)._These_cases_represented_6.1%_of_410_newly_diagnosed_ALLs_(two_treatment_protocols)_and_16.8%_of_95_AMLs_(two_protocols)._T-lineage--associated_antigens_were_identified_in_9_of_the_My+_ALL_cases_and_in_14_of_those_classified_as_Ly+_AML;_all_but_1_of_the_19_cases_that_could_be_subclassified_had_an_early_thymocyte_stage_of_differentiation._The_My+_ALL_cases_had_an_increased_frequency_of_French-American-British_(FAB)_L2_morphology_(36%);_the_Ly+_AML_cases_were_characterized_by_FAB_M1_or_M2_morphology,_low_levels_of_myeloperoxidase_reactivity_and_combined_populations_of_myeloperoxidase-positive_large_blasts_and_small_blasts_generally_of_hand-mirror_morphology._Karyotypic_abnormalities_included_t(9;22)(q34;q11)_in_three_cases_of_My+_ALL,_11q23_translocations_in_two_cases_of_My+_ALL,_and_14q32_translocations_in_three_My+_ALL_and_five_Ly+_AML_cases._Mixed-lineage_expression_lacked_prognostic_significance_in_either_ALL_or_AML;_however,_the_findings_indicate_that_some_patients_with_Ly+_AML_may_respond_to_prednisone,_vincristine,_and_L-asparaginase_after_failing_on_protocols_for_myeloid_leukemia._At_relapse,_two_My+_ALLs_had_converted_to_AML_and_two_Ly+_AMLs_to_ALL;_one_case_in_each_group_showed_complete_replacement_of_the_original_karyotype._Acute_mixed-lineage_leukemia_does_not_adequately_describe_the_heterogeneity_of_the_cases_identified_in_this_study_and_should_be_replaced_by_a_set_of_more_restrictive_terms_that_indicate_the_unique_biologic_features_of_these_leukemias.